Open access

SARS-CoV-2 infections in pediatric and young adult recipients of chimeric antigen receptor T-cell therapy: an international registry report
Kevin Owen McNerney, Rebecca M Richards, Paibel Aguayo-Hiraldo, Friso G Calkoen, Julie-An Talano, Amy Moskop, Adriana Balduzzi, Jennifer Krajewski, Hema Dave, Anant Vatsayan, Colleen Callahan, Hongyan Liu, Yimei Li, Kara Lynn Davis, Shannon L Maude

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e005957; DOI: 10.1136/jitc-2022-005957
Trojan-horse silk fibroin nanocarriers loaded with a re-call antigen to redirect immunity against cancer
Elia Bari, Francesca Ferrera, Tiziana Altosole, Sara Perteghella, Pierluigi Mauri, Rossana Rossi, Giulia Passignani, Luca Mastracci, Martina Galati, Giuseppina Iliana Astone, Maddalena Mastrogiacomo, Patrizio Castagnola, Daniela Fenoglio, Dario Di Silvestre, Maria Luisa Torre, Gilberto Filaci

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e005916; DOI: 10.1136/jitc-2022-005916
Correction: Adaptive single-KIR⁺NKG2C⁺ NK cells expanded from select superdonors show potent missing-self reactivity and efficiently control HLA-mismatched acute myeloid leukemia
Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e005577corr1; DOI: 10.1136/jitc-2022-005577corr1
TYRO3 blockade enhances anti-PD-1 therapy response by modulating expression of CCN1 in tumor microenvironment
Miso Park, Da-Sol Kuen, Jaewoo Park, Munkyung Choi, Yeonji Kim, Eun Chae Roh, Yong June Choi, Yoon Gyoon Kim, Yeonseok Chung, Sung Yun Cho, Keon Wook Kang

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e006084; DOI: 10.1136/jitc-2022-006084
Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections
Jelmer H van Puffelen, Boris Novakovic, Liesbeth van Emst, Denise Kooper, Tahlita C M Zuiverloon, Ursula T H Oldenhof, J Alfred Witjes, Tessel E Galesloot, Alina Vrieling, Katja K H Aben, Lambertus A L M Kiemeney, Egbert Oosterwijk, Mihai G Netea, Joost L Boormans, Antoine G van der Heijden, Leo A B Joosten, Sita H Vermeulen

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e005518; DOI: 10.1136/jitc-2022-005518
Diabetes insipidus and Guillain-Barré-like syndrome following CAR-T cell therapy: a case report
Christian Koch, Juliane Fleischer, Todor Popov, Karl Frontzek, Bettina Schreiner, Patrick Roth, Markus G. Manz, Simone Unseld, Antonia M. S. Müller, Norman F. Russkamp

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e006059; DOI: 10.1136/jitc-2022-006059
Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in patients with advanced solid tumors
Charles M Rudin, Hardev S Pandha, Matthew Zibelman, Wallace L Akerley, Kevin J Harrington, Daphne Day, Andrew G Hill, Steven J O'Day, Timothy D Clay, Gavin M Wright, Ross R Jennens, David E Gerber, Jonathan E Rosenberg, Christy Ralph, David C Campbell, Brendan D Curti, Jaime R Merchan, Yixin Ren, Emmett V Schmidt, Lisa Guttman, Sumati Gupta

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e005007; DOI: 10.1136/jitc-2022-005007
Liquid biopsies coming of age: biology, emerging technologies, and clinical translation- An introduction to the JITC expert opinion special review series on liquid biopsies
Mark D. Stewart, Valsamo Anagnostou

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e006367; DOI: 10.1136/jitc-2022-006367
Next-generation ctDNA-driven clinical trials in precision immuno-oncology
Charu Aggarwal, Natasha B Leighl

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e006397; DOI: 10.1136/jitc-2022-006397
Soluble and cell-based markers of immune checkpoint inhibitor-associated nephritis
Meghan E Sise, Qiyu Wang, Harish Seethapathy, Daiana Moreno, Destiny Harden, R Neal Smith, Ivy A Rosales, Robert B Colvin, Sarah Chute, Lynn D Cornell, Sandra M Herrmann, Riley Fadden, Ryan J Sullivan, Nancy J Yang, Sara Barmettler, Sophia Wells, Shruti Gupta, Alexandra-Chloe Villani, Kerry L Reynolds, Jocelyn Farmer

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e006222; DOI: 10.1136/jitc-2022-006222

Main menu

Open access

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Open access

Pages